Yasuhara and Shingo 2004)
First-time user protocol If you have never used DSIP before, conservative initial dosing prevents wasted product and unwanted side effects
Fatty acids that have this role include the long-chain polyunsaturated fatty acids (PUFAs) of the omega-3 and omega-6 classes
Further modifications, in conjunction with the creation of protein complexes, ultimately lead to the deposition of melanin into a fibrillar scaffold, primarily composed of altered PMEL17 (also known as gp100) molecules
Oral or troche dose: Determined at APRN intake based on your GI indication and treatment goal Troche format: Held sublingually for 60 to 90 seconds before swallowing for improved absorption Best use case: GI inflammation, IBS, gut lining repair, Crohns management, systemic anti-inflammatory support Not optimal for: Localized tendon, joint, or muscle injury where injection near the site is more targeted Injury vs Gut Protocol: See What Dosing Looks Like for Your Use Case BPC-157 dosage differs by indication